Propavan 25 mg tablets

Propavan is a established pharmaceutical product containing propiomazine, a sedative frequently prescribed for sleep disorders. Originally developed in Europe, the brand was a staple of the Swedish pharmaceutical company Pharmacia for many decades. Throughout various industry mergers including Pharmacia sub-divisions and Pfizer, the marketing rights were eventually transferred to specialty pharmaceutical firms.

Currently, Propavan is owned by CNX Therapeutics, a company that specializes in acquiring and revitalizing heritage pharmaceutical brands within the CNS (Central Nervous System) and critical care sectors. While CNX Therapeutics is headquartered in the United Kingdom, they utilize a global supply chain for their ingredients and manufacturing processes across various European facilities to ensure availability in Northern European markets where the drug remains a standard treatment.